摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

[5-(2-氨基-6-氧代-3H-嘌呤-9-基)-3,4-二羟基四氢呋喃-2-基]甲基[5-(6-氨基嘌呤-9-基)-4-羟基-2-(羟基甲基)四氢呋喃-3-基]磷酸氢酯 | 3352-23-6

中文名称
[5-(2-氨基-6-氧代-3H-嘌呤-9-基)-3,4-二羟基四氢呋喃-2-基]甲基[5-(6-氨基嘌呤-9-基)-4-羟基-2-(羟基甲基)四氢呋喃-3-基]磷酸氢酯
中文别名
——
英文名称
ApG
英文别名
Adenylyl-(3'->5')-guanosine;[(2R,3S,4R,5R)-5-(2-amino-6-oxo-1H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl [(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate
[5-(2-氨基-6-氧代-3H-嘌呤-9-基)-3,4-二羟基四氢呋喃-2-基]甲基[5-(6-氨基嘌呤-9-基)-4-羟基-2-(羟基甲基)四氢呋喃-3-基]磷酸氢酯化学式
CAS
3352-23-6
化学式
C20H25N10O11P
mdl
——
分子量
612.453
InChiKey
LWBLDUTUVIXFJE-INFSMZHSSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 密度:
    2.41±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    -5.8
  • 重原子数:
    42
  • 可旋转键数:
    8
  • 环数:
    6.0
  • sp3杂化的碳原子比例:
    0.5
  • 拓扑面积:
    310
  • 氢给体数:
    8
  • 氢受体数:
    17

SDS

SDS:cd74427a4edc29077096b7c6371acebd
查看

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Catalysis of Diribonucleoside Monophosphate Cleavage by Water Soluble Copper(II) Complexes of Calix[4]arene Based Nitrogen Ligands
    作者:Roberta Cacciapaglia、Alessandro Casnati、Luigi Mandolini、David N. Reinhoudt、Riccardo Salvio、Andrea Sartori、Rocco Ungaro
    DOI:10.1021/ja0632106
    日期:2006.9.1
    Calix[4]arenes functionalized at the 1,2-, 1,3-, and 1,2,3-positions of the upper rim with [12]ane-N-3 ligating units were synthesized, and their bi-and trimetallic zinc(II) and copper( II) complexes were investigated as catalysts in the cleavage of phosphodiesters as RNA models. The results of comparative kinetic studies using monometallic controls indicate that the subunits of all of the zinc(II) complexes and of the 1,3-distal bimetallic copper(II) complex 7-Cu-2 act as essentially independent monometallic catalysts. The lack of cooperation between metal ions in the above complexes is in marked contrast with the behavior of the 1,2-vicinal bimetallic copper(II) complex 6-Cu-2, which exhibits high catalytic efficiency and high levels of cooperation between metal ions in the cleavage of HPNP and of diribonucleoside monophosphates NpN'. A third ligated metal ion at the upper rim does not enhance the catalytic efficiency, which excludes the simultaneous cooperation in the catalysis of the three metal ions in 8-Cu-3. Rate accelerations relative to the background brought about by 6-Cu-2 and 8-Cu-3 (1.0 mM catalyst, water solution, pH 7.0, 50 degrees C) are on the order of 10(4)-fold, largely independent of the nucleobase structure, with the exception of the cleavage of diribonucleoside monophosphates in which the nucleobase N is uracil, namely UpU and UpG, for which rate enhancements rise to 10(5)-fold. The rationale for the observed selectivity is discussed in terms of deprotonation of the uracil moiety under the reaction conditions and complexation of the resulting anion with one of the copper(II) centers.
  • The p<i>K</i><sub>a</sub> of the Internucleotidic 2‘-Hydroxyl Group in Diribonucleoside (3‘→5‘) Monophosphates
    作者:S. Acharya、A. Földesi、J. Chattopadhyaya
    DOI:10.1021/jo026545o
    日期:2003.3.1
    Ionization of the internucleotidic 2'-hydroxyl group in RNA facilitates transesterification reactions in Group I and II introns (splicing), hammerhead and hairpin ribozymes, self-cleavage in lariat-RNA, and leadzymes and tRNA processing by RNase P RNA, as well as in some RNA cleavage reactions promoted by ribonucleases. Earlier, the pK(a) of 2'-OH in mono- and diribonucleoside (3'-->5') monophosphates had been measured under various nonuniform conditions, which make their comparison difficult. This work overcomes this limitation by measuring the pK(a) values for internucleotidic 2'-OH of eight different diribonucleoside (3'-5') monophosphates under a set of uniform noninvasive conditions by H-1 NMR. Thus the pK(a) is 12.31 (+/-0.02) for ApG and 12.41 (+/-0.04) for ApA, 12.73 (+/-0.04) for GpG and 12.71 (+/-0.08) for GpA, 12.77 (+/-0.03) for CpG and 12.88 (+/-0.02) for CpA, and 12.76 (+/-0.03) for UpG and 12.70 (+/-0.03) for UpA. By comparing the pK(a)s of the respective 2'-OH of monomeric nucleoside 3'-ethyl phosphates with that of internucleotidic 2'-OH in corresponding diribonucleoside (3'-5') monophosphates, it has been confirmed that the aglycons have no significant effect on the pKa values of their 2'-OH under our measurement condition, except for the internucleotidic 2'-OH of 9-adeninyl nucleotide at the 5'-end (ApA and ApG), which is more acidic by 0.3-0.4 pK(a) units.
  • Sequence-dependent platinum chelation by adenylyl(3'-5')guanosine and guanylyl(3'-5')adenosine reacting with cis-diamminedichloroplatinum(II) and its diaqua derivative
    作者:Bruno Van Hemelryck、Jean Pierre Girault、Genevieve Chottard、Philippe Valadon、Abdelazize Laoui、Jean Claude Chottard
    DOI:10.1021/ic00253a003
    日期:1987.3
  • Jamoulle; Torrence, European Journal of Medicinal Chemistry, 1986, vol. 21, # 6, p. 517 - 519
    作者:Jamoulle、Torrence
    DOI:——
    日期:——
  • KOMIYAMA, MAKOTO;TAKESHIGE, YUICHI, J. ORG. CHEM., 54,(1989) N0, C. 4936-4939
    作者:KOMIYAMA, MAKOTO、TAKESHIGE, YUICHI
    DOI:——
    日期:——
查看更多

同类化合物

鸟苷酰-(3'-5')-尿苷 鸟苷酰(3'-5')尿苷3'-单磷酸酯 腺苷酰基-(3,’5’)-胞苷 腺苷酰-(3'→5')-胞苷 腺苷酰-(3'-5')-尿苷3'-单磷酸酯 腺苷基3'-5'-腺苷铵盐 脱氧鸟苷酰-(3'-5')-脱氧腺苷 脱氧腺苷酰-(3'-5')-脱氧鸟苷 脱氧胞苷酰-(3'-5')-脱氧鸟苷 胸苷酰(3'->5')胸苷铵盐 胸苷基(3'5')-2'-脱氧腺苷铵盐 胞苷酰-(5'->3')-鸟苷 胞苷酰-(3',5')-鸟苷 胞苷酰(3'->5')尿苷铵盐 聚(2-氨基脱氧腺嘌呤基-5-碘脱氧尿苷酸) 聚(2-氨基脱氧腺嘌呤基-5-溴脱氧尿苷酸) 环二腺苷酸 尿酸氧化酶 尿苷酰基-(3',5')-尿苷 二(3',5')-环二鸟苷酸 乙基3,4,5-三[[(6-重氮基-5,6-二氢-5-羰基-1-萘基)磺基基]氧代]苯酸酯 [5-(6-氨基嘌呤-9-基)-4-羟基-2-(羟基甲基)四氢呋喃-3-基][5-(2,4-二氧代嘧啶-1-基)-3,4-二羟基四氢呋喃-2-基]甲基磷酸氢酯 [5-(6-氨基嘌呤-9-基)-3,4-二羟基-四氢呋喃-2-基]甲基[羟基-[2,3,4-三羟基-5-(7-甲基-2,4,8-三氧代-1H-嘧啶并[4,5-b]喹啉-10-基)戊氧基]磷酰]磷酸氢酯 [5-(4-氨基-2-氧代-嘧啶-1-基)-3,4-二羟基-四氢呋喃-2-基]甲基[5-(4-氨基-2-氧代-嘧啶-1-基)-4-羟基-2-(羟基甲基)四氢呋喃-3-基]磷酸氢酯 [5-(2-氨基-6-氧代-3H-嘌呤-9-基)-3,4-二羟基四氢呋喃-2-基]甲基[5-(6-氨基嘌呤-9-基)-4-羟基-2-(羟基甲基)四氢呋喃-3-基]磷酸氢酯 [(2R,3S,5R)-5-(6-氨基嘌呤-9-基)-2-(膦酰氧基甲基)四氢呋喃-3-基][(2R,3S,5R)-5-(2,4-二氧代嘧啶-1-基)-3-羟基四氢呋喃-2-基]甲基磷酸氢酯 [(2R,3S,5R)-5-(4-氨基-2-氧代嘧啶-1-基)-3-羟基四氢呋喃-2-基]甲基 [(2R,3S,5R)-2-(羟基甲基)-5-(5-甲基-2,4-二氧代嘧啶-1-基)四氢呋喃-3-基]磷酸氢酯 [(2R,3S,5R)-5-(4-氨基-2-氧代嘧啶-1-基)-2-(膦酰氧基甲基)四氢呋喃-3-基][(2R,3S,4R,5R)-5-(6-氨基嘌呤-9-基)-3,4-二羟基四氢呋喃-2-基]甲基磷酸氢酯 [(2R,3S,4R,5R)-5-(6-氨基嘌呤-9-基)-3,4-二羟基四氢呋喃-2-基]甲基[(2R,3S,4R,5R)-5-(2,4-二氧代嘧啶-1-基)-4-羟基-2-(羟基甲基)四氢呋喃-3-基]磷酸氢酯 [(2R,3S,4R,5R)-5-(2-氨基-6-氧代-3H-嘌呤-9-基)-3,4-二羟基四氢呋喃-2-基]甲基[(2R,3S,4R,5R)-5-(2-氨基-6-氧代-3H-嘌呤-9-基)-4-羟基-2-(羟基甲基)四氢呋喃-3-基]磷酸氢酯 8-氯-黄素腺嘌呤二核苷酸 8-巯基-黄素腺嘌呤二核苷酸 5'-O-胸苷酰 3'-O-(2'-脱氧腺苷)硫代磷酸酯 2'-脱氧鸟苷酰-(5'-3')-2'-脱氧-5'-鸟苷酸 2'-脱氧鸟苷酰-(3'-5')-2'-脱氧胞苷 2'-脱氧腺苷酰-(3'-5')-2'-脱氧腺苷 2'-脱氧胞啶基(3'->5')-2'-脱氧鸟苷铵盐 1-(2-脱氧-5-O-磷羧基五呋喃糖基)-5-[(1E)-3-{[5-(2-羰基六氢-1H-噻吩并[3,4-d]咪唑-4-基)戊酰基]氨基}丙-1-烯-1-基]嘧啶-2,4(1H,3H)-二酮 5'-dCT 2'-deoxyadenylyl-(3',5')-thymidine ammonium salt d(GpT) [(2R,3R,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-2-(hydroxymethyl)-4-methoxyoxolan-3-yl] [(2R,3R,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3-hydroxy-4-prop-2-ynoxyoxolan-2-yl]methyl hydrogen phosphate pA3'p5'U pG3'p5'U pG3'p5'C cytidylyl-(3'-5')-3'-amino-3'-deoxy-3'-L-phenylalanyl-N6,N6-dimethyladenosine adenylyl-(3',5')-guanosine deoxyadenosyl(5'-3')thymidine phosphate cAIMP N4-palmitoyl-2'-deoxycytidylyl-(3'->5')-5-fluoro-2'-deoxyuridine